The correlation analysis between TUBA1C expression and the clinical characteristics of these samples showed that high TUBA1C expression was correlated with survival time (P = 0.032), survival status (P = 0.043), and tumor size (P = 0.005) (Fig 3B, 3C and 3F). This evidence concerns the gene TUBA1C and neoplasm.